Erica Pyles

1.8k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Erica Pyles is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Erica Pyles has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Erica Pyles's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Protein purification and stability (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Erica Pyles is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Protein purification and stability (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Erica Pyles collaborates with scholars based in United States. Erica Pyles's co-authors include Neil Stahl, Stanley J. Wiegand, Nicholas Papadopoulos, George D. Yancopoulos, Michael Rosconi, Ashique Rafique, Ergang Shi, Joel Martin, Qin Ruan and Gavin Thurston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Journal of Chromatography A.

In The Last Decade

Erica Pyles

16 papers receiving 1.0k citations

Hit Papers

Binding and neutralization of vascular endothelial growth... 2012 2026 2016 2021 2012 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    2012 823 citations Nicholas Papadopoulos, Joel Martin et al. Angiogenesis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica Pyles United States 7 631 587 415 144 94 18 1.1k
F Bacin France 11 363 0.6× 272 0.5× 183 0.4× 154 1.1× 28 0.3× 69 709
Virginia Picasso Italy 12 157 0.2× 29 0.0× 314 0.8× 400 2.8× 197 2.1× 16 661
Sherry Yang United States 10 83 0.1× 65 0.1× 210 0.5× 305 2.1× 13 0.1× 32 645
Michela Croce Italy 21 134 0.2× 38 0.1× 436 1.1× 490 3.4× 510 5.4× 47 1.2k
Giuseppe Gullo Ireland 13 35 0.1× 88 0.1× 271 0.7× 368 2.6× 41 0.4× 42 692
Christophe Lahorte Belgium 12 18 0.0× 261 0.4× 316 0.8× 67 0.5× 77 0.8× 19 583
Jay Overholser United States 11 15 0.0× 138 0.2× 439 1.1× 358 2.5× 186 2.0× 16 767
J B Little United States 14 25 0.0× 234 0.4× 336 0.8× 272 1.9× 16 0.2× 22 620
James H. Murray United States 11 10 0.0× 208 0.4× 281 0.7× 238 1.7× 109 1.2× 18 707
Michiko Harao Japan 16 13 0.0× 87 0.1× 362 0.9× 329 2.3× 377 4.0× 36 915

Countries citing papers authored by Erica Pyles

Since Specialization
Citations

This map shows the geographic impact of Erica Pyles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Pyles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Pyles more than expected).

Fields of papers citing papers by Erica Pyles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica Pyles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Pyles. The network helps show where Erica Pyles may publish in the future.

Co-authorship network of co-authors of Erica Pyles

This figure shows the co-authorship network connecting the top 25 collaborators of Erica Pyles. A scholar is included among the top collaborators of Erica Pyles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica Pyles. Erica Pyles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Peng, Wenjing, Cristinel Sandu, Yuetian Yan, et al.. (2025). A target affinity enrichment workflow to characterize critical post-translational modifications within therapeutic antibodies. Journal of Pharmaceutical Sciences. 114(5). 103710–103710. 1 indexed citations
2.
Townsend, Julia A., Shuai Li, Michael Rosconi, et al.. (2025). Comparative analysis of empty and full adeno-associated viruses under stress conditions by anion-exchange chromatography, analytical ultracentrifugation, and mass photometry. Journal of Pharmaceutical Sciences. 114(2). 1237–1244. 2 indexed citations
3.
4.
Liu, Sophia, Jennifer B. Nguyen, Sunnie S. Y. Kim, et al.. (2024). Development of a platform method for rapid detection and characterization of domain-specific post-translational modifications in bispecific antibodies. Journal of Pharmaceutical and Biomedical Analysis. 244. 116120–116120. 3 indexed citations
5.
Henderson, Steven, et al.. (2024). Comparison of capillary electrophoresis-based methods for the analytical characterization of purity and stability of in vitro transcribed mRNA. Journal of Pharmaceutical and Biomedical Analysis. 249. 116352–116352. 5 indexed citations
6.
Henderson, Steven, et al.. (2024). Comprehensive chromatographic assessment of forced degraded in vitro transcribed mRNA. Journal of Chromatography A. 1722. 464885–464885. 6 indexed citations
7.
8.
9.
Abdubek, Polat, et al.. (2023). Comprehensive biophysical characterization of AAV-AAVR interaction uncovers serotype- and pH-dependent interaction. Journal of Pharmaceutical and Biomedical Analysis. 234. 115562–115562. 4 indexed citations
10.
Kaur, Keerat, et al.. (2023). A single-nucleotide resolution capillary gel electrophoresis workflow for poly(A) tail characterization in the development of mRNA therapeutics and vaccines. Journal of Pharmaceutical and Biomedical Analysis. 236. 115692–115692. 9 indexed citations
11.
Xu, Xiaobin, Yuan Cao, Matthew C. Franklin, et al.. (2022). Deciphering the High Viscosity of a Therapeutic Monoclonal Antibody in High Concentration Formulations by Microdialysis-Hydrogen/Deuterium Exchange Mass Spectrometry. Journal of Pharmaceutical Sciences. 111(5). 1335–1345. 2 indexed citations
12.
Marlow, Michael S., et al.. (2022). Human Serum Albumin Mitigates Formation of Fatty Acid Particles in Polysorbate-Containing Solutions. Journal of Pharmaceutical Sciences. 111(11). 3185–3188. 5 indexed citations
13.
Wu, Zhijie, Yu Huang, Xueqing Zhao, et al.. (2022). High-sensitivity and high-resolution therapeutic antibody charge variant and impurity characterization by microfluidic native capillary electrophoresis-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 223. 115147–115147. 19 indexed citations
14.
DaSilva, John O., Andrés E. Perez Bay, Julian Andreev, et al.. (2019). A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models. Clinical Cancer Research. 26(6). 1408–1419. 23 indexed citations
15.
Chen, Jihua, Kun Lu, Nisha Palackal, et al.. (2019). Mitigating Target Interference in Bridging Immunogenicity Assay with Target-Blocking Reagents and Mild Basic pH. Bioanalysis. 11(17). 1569–1580. 8 indexed citations
16.
Partridge, Michael A., Robert N. Dreyer, Thomas J. Daly, et al.. (2015). Matrix Interference from Fc–Fc Interactions in Immunoassays for Detecting Human Igg4 Therapeutics. Bioanalysis. 7(20). 2701–2712. 3 indexed citations
17.
Papadopoulos, Nicholas, Joel Martin, Qin Ruan, et al.. (2012). Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis. 15(2). 171–185. 823 indexed citations breakdown →
18.
Rudge, John S., Jocelyn Holash, Donna Hylton, et al.. (2007). VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade. Proceedings of the National Academy of Sciences. 104(47). 18363–18370. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Bacin Breakdown of academic impact, for papers by Virginia Picasso Breakdown of academic impact, for papers by Sherry Yang Breakdown of academic impact, for papers by Michela Croce Breakdown of academic impact, for papers by Giuseppe Gullo Breakdown of academic impact, for papers by Christophe Lahorte Breakdown of academic impact, for papers by Jay Overholser Breakdown of academic impact, for papers by J B Little Breakdown of academic impact, for papers by James H. Murray Breakdown of academic impact, for papers by Michiko Harao
Rankless by CCL
2026